日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined Treatment With Lipoprotein Apheresis and Hemodialysis in Patients With Severe Cardiovascular Disease, High Lipoprotein(a) and End Stage Renal Disease

对患有严重心血管疾病、高脂蛋白(a)和终末期肾病的患者进行脂蛋白分离术和血液透析联合治疗

Röseler, Tilmann; Kayser, Daniel; Schlieper, Georg; Bernhardt, Wanja M

The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis

Raf激酶抑制剂PLX5568可减缓大鼠多囊肾病中囊肿的增殖,但会促进肾脏和肝脏纤维化。

Buchholz, Bjoern; Klanke, Bernd; Schley, Gunnar; Bollag, Gideon; Tsai, James; Kroening, Sven; Yoshihara, Daisuke; Wallace, Darren P; Kraenzlin, Bettina; Gretz, Norbert; Hirth, Peter; Eckardt, Kai-Uwe; Bernhardt, Wanja M

Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD

抑制脯氨酰羟化酶可增加终末期肾病患者的促红细胞生成素生成。

Bernhardt, Wanja M; Wiesener, Michael S; Scigalla, Paul; Chou, James; Schmieder, Roland E; Günzler, Volkmar; Eckardt, Kai-Uwe

HIF activation protects from acute kidney injury

HIF激活可保护肾脏免受急性损伤

Weidemann, Alexander; Bernhardt, Wanja M; Klanke, Bernd; Daniel, Christoph; Buchholz, Björn; Câmpean, Valentina; Amann, Kerstin; Warnecke, Christina; Wiesener, Michael S; Eckardt, Kai-Uwe; Willam, Carsten

Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

缺氧通过 HIF-1 刺激上皮间质转化促进体内纤维化

Higgins Debra F, Kimura Kuniko, Bernhardt Wanja M, Shrimanker Nikita, Akai Yasuhiro, Hohenstein Bernd, Saito Yoshihiko, Johnson Randall S, Kretzler Matthias, Cohen Clemens D, Eckardt Kai-Uwe, Iwano Masayuki, Haase Volker H